How to avoid ‘adore’ plastic surgery
A doctor has discovered the ‘adores’ surgical procedure can actually cause cancer.
The surgery involves removing a section of the urethra and inserting a small piece of plastic.
It is the latest research into plastic surgery that has linked it to cancer.
Researchers at the University of Washington said in a paper published last month in the Journal of the American Medical Association that a plastic surgeon who performed the procedure was found to have elevated levels of tumor necrosis factor-alpha, or TNF-alpha.
TNF-α is known to damage tissue and can lead to cancer and autoimmune disease.
Dr. J. Paul McEwen, director of the National Cancer Institute, said the TNF levels are normal and not dangerous.
“TNF is an immune system-related gene, which is associated with normal cells, healthy tissues, and the ability of normal tissues to repair damage,” McEwan said.
When a plastic surgery patient has TNF, their immune system attacks normal tissue and damages it.
The cancer cells can then invade normal tissues, causing tumors.
McEwen said TNF has been linked to breast, lung, and prostate cancer.
In the latest study, McEwin and his colleagues took a group of patients who had undergone breast surgery and injected them with the TNI-alpha gene, while their cancer cells were being targeted by TNF.
While some of the cancer cells survived, others had to be removed surgically and put in an induced-mortality group, which was able to prevent the tumors from forming.
“What we found is that TNF causes these cancer cells to die, but they’re not dying and they’re still in the bloodstream, which allows them to grow and spread,” McElwain said.
“In the end, the tumors that were found to be most malignant, the ones that caused the most damage to healthy tissue, are those that have been injected with the gene that causes TNF,” McEllie said.
The researchers are now testing whether TNF can be used as a treatment for prostate cancer, a cancer that kills about 1 in every 4 men in the U.S. and can be spread through the air.
The new study is just the latest in a string of studies to link TNF to cancer, but McEllies work was the first to find that a TNF injection could help prevent tumors from growing.
“We found that TNI reduces the risk of cancers in the lungs and brain, which are very important areas of cancer research,” McDougall said.
McEllie also said TNI has shown promise in preventing breast cancer, as well as ovarian, ovarian, prostate, and pancreatic cancers.
“It seems to work well in other areas, such as lung cancer, liver cancer, lung transplantation, colon cancer, prostate cancer,” he said.
Dr. Robert W. Fagerl said in an interview with the Associated Press that the technique is “very safe.”
Fagerl, director and co-founder of the Institute of Oncology at Emory University, has been studying TNF and other immune cells in cancer patients for more than 30 years.
He said that there is a strong correlation between the TGF-beta gene and TNF.
“In the past, the TF-alpha receptor has been thought to be a cancer killer, but it has not been known to cause tumors,” he told the AP.
He said TF is important in fighting cancer because it triggers an immune response that shuts down the cells.
IoT is the body’s immune system, FagerL said.
It has been shown to suppress cancer cells, but that doesn’t mean it’s always effective.
“If you use the wrong way, it can do harm.
The way to stop cancer is to have the right way,” Fagerld said.
Fagerld is hopeful the new study will lead to more treatments for TNF so that it can be tested for other potential side effects.
“I think it’s a really good example of how these things can be really helpful in treating the same disease in different ways,” he added.
Follow NBC Asian America on Facebook, Twitter, Instagram and Tumblr.